Preliminary > Science and Technology > Biotechnology > COVID 19
Why in news? Bharat Biotech International Limited announced that iNCOVACC, has received approval from the Drugs Controller General of India (DCGI) under Restricted Use in Emergency Situations for ages 18 and above,...
Preliminary > Science and Technology > Biotechnology > COVID 19
Why in news? The Pune-based Gennova Biopharmaceuticals is expected to roll out India’s first home-grown mRNA (messenger ribonucleic acid) vaccine by April 2022. More about the news: The COVID-19 pa...
Preliminary > Science and Technology > Miscellaneous > COVID 19
Why in news? India gave emergency-use authorisation to two more vaccines- Corbevax and Covovax. About Corbevax: Corbevax was developed by Hyderabad-based biopharmaceutical firm Biological E., the Baylor ...
Preliminary > Science and Technology > Miscellaneous > COVID 19
Why in news? Researchers have developed an experimental chewing gum that traps SARS-CoV-2 viral particles, the coronavirus that causes Covid-19. Scientists designed the gum with plant-derived ACE2 proteins with t...
Preliminary > Disaster Management > Disasters > COVID 19
Why in news? An expert panel of India's Central Drug Authority, which recently reviewed Serum Institute's application seeking emergency authorisation of COVID-19 vaccine Covovax, has sought additional data ...
Preliminary > Disaster Management > Disasters > COVID 19
Why in news? The World Health Organisation (WHO) designated SARS-CoV-2 variant B.1.1529 (named as Omicron) as a ‘variant of concern’. About Omicron Variant: This variant was first detected in...
Preliminary > Science and Technology > Miscellaneous > COVID 19
Why in news India’s first indigenous COVID-19 vaccine, Bharat Biotech’s Covaxin, was granted Emergency Use Listing (EUL) by the World Health Organization (WHO) on 3rd November 2021. More about the ...
Preliminary > Social Justice > Health > COVID 19
Why in news? The decline in daily new infections across India has prompted INSACOG, the consortium of labs focussed on sequencing coronavirus variants, to prioritise new surveillance approaches. About INSACOG ...
Preliminary > Disaster Management > Miscellaneous > COVID 19
Why in news? Prime minister’s Citizen Assistance and Relief in Emergency Situation Fund (PM-CARES Fund), a charitable trust under the law, has told Delhi High Court that the trust’s fund is not a fund of the Go...
Preliminary > Science and Technology > Miscellaneous > COVID 19
Why in news? The Drug Controller General has granted emergency approval to the Zycov-D, a COVID-19 vaccine developed by the Ahmedabad based Zydus Cadilla group, on 20th August, making it the first vaccine in India ...